Investment Summary

Excellere Partners Invests In Molecular Designs

On October 1, 2021, private equity firm Excellere Partners invested in life science company Molecular Designs

Investment Highlights
  • This is Excellere Partners’ 4th transaction in the Life Science sector.
  • This is Excellere Partners’ 25th transaction in the United States.
  • This is Excellere Partners’ 1st transaction in Alabama.

Investment Summary
Date 2021-10-01
Target Molecular Designs
Sector Life Science
Investor(s) Excellere Partners
Deal Type Growth Capital

Target

Molecular Designs

Birmingham, Alabama, United States
Molecular Designs is a developer, manufacturer, and supplier of multiplex assays for molecular testing and research. Utilizing time-tested PCR to identify pathogens rapidly not only improves patient care but also advances antibiotic stewardship. Molecular Designs was founded in 2019 and is based in Birmingham, Alabama.

Search 199,442 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Excellere Partners

Denver, Colorado, United States
Category Private Equity Firm
Founded 2006
PE ASSETS 2.3B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Excellere Partners is a private equity firm focused on mid-market recapitalizations, management buyouts, and consolidation opportunities. Excellere looks to partner with management on transactions and targets opportunities in business services, education/training, healthcare, industrial services, and specialty foods. Excellere Partners was formed in 2006 and is based in Denver, Colorado.

DEAL STATS #
Overall 25 of 25
Sector (Life Science) 4 of 4
Type (Growth Capital) 14 of 14
State (Alabama) 1 of 1
Country (United States) 25 of 25
Year (2021) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-21 SCA Pharma

Little Rock, Arkansas, United States

SCA Pharma specializes in preparing sterile pharmaceuticals customized for hospital pharmacies and healthcare facilities nationwide. SCA Pharmaceuticals products and services have consistently proven to significantly increase efficiencies and reduce costs to these organizations. SCA Pharma was founded in 2010 and is based in Little Rock, Arkansas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-09 Biocare Medical

Pacheco, California, United States

Biocare Medical is a provider of immunohistochemistry (IHC) instrumentation, as well as a full range of reagents for IHC and molecular testing. The company engages in IHC and molecular diagnostic reagents, including simultaneous Multiplex IHC tests that provide increased confidence at critical diagnostic decision points, positively influencing patient therapy while accelerating turnaround time. Biocare Medical was formed in 1997 and is based in Pacheco, California.

Sell -
Mergr

Product

Company

Legal